-
1
-
-
0028929516
-
Radioiodine therapy of Graves' hyperthyroidism: Standard vs. calculated 131-I activity. Results of a prospective, randomised, multicentre study
-
0014-2972
-
H. Peters, C. Fischer, U. Bogner, and H. Schleusener, " Radioiodine therapy of Graves' hyperthyroidism: Standard vs. calculated 131-I activity. Results of a prospective, randomised, multicentre study.," Eur. J. Clin. Invest. 25, 186-193 (1995). 0014-2972
-
(1995)
Eur. J. Clin. Invest.
, vol.25
, pp. 186-193
-
-
Peters, H.1
Fischer, C.2
Bogner, U.3
Schleusener, H.4
-
2
-
-
0032875173
-
Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: Is more than seven-thousand rad target dose necessary?
-
1050-7256
-
L. Bajnok, E. Mezosi, E. Nagy, J. Szabo, I. Sztojka, J. Varga, L. Galuska, and A. Leovey, " Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: Is more than seven-thousand rad target dose necessary? " Thyroid 9, 865-869 (1999). 1050-7256
-
(1999)
Thyroid
, vol.9
, pp. 865-869
-
-
Bajnok, L.1
Mezosi, E.2
Nagy, E.3
Szabo, J.4
Sztojka, I.5
Varga, J.6
Galuska, L.7
Leovey, A.8
-
3
-
-
0034795484
-
Determination of the optimal minimum radioiodine dose in patients with Graves' disease. A clinical outcome study
-
0340-6997 10.1007/s002590100621.
-
D. Howarth, M. Epstein, L. Lan, P. Tan, and J. Booker, " Determination of the optimal minimum radioiodine dose in patients with Graves' disease. A clinical outcome study.," Eur. J. Nucl. Med. 0340-6997 10.1007/s002590100621 28, 1489-1495 (2001).
-
(2001)
Eur. J. Nucl. Med.
, vol.28
, pp. 1489-1495
-
-
Howarth, D.1
Epstein, M.2
Lan, L.3
Tan, P.4
Booker, J.5
-
4
-
-
0036366552
-
Radioiodine therapy in Graves' disease based on tissue absorbed dose calculations: Effect of pre-treatment thyroid volume on clinical outcome
-
0340-6997
-
M. J. Reinhardt, I. Brink, A. Y. Joe, D. von Mallek, S. Ezziddin, H. Palmedo, and T. M. Krause, " Radioiodine therapy in Graves' disease based on tissue absorbed dose calculations: Effect of pre-treatment thyroid volume on clinical outcome.," Eur. J. Nucl. Med. 29, 1118-1124 (2002). 0340-6997
-
(2002)
Eur. J. Nucl. Med.
, vol.29
, pp. 1118-1124
-
-
Reinhardt, M.J.1
Brink, I.2
Joe, A.Y.3
Von Mallek, D.4
Ezziddin, S.5
Palmedo, H.6
Krause, T.M.7
-
5
-
-
85027228313
-
-
Council Directive 97/43/EURATOM on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, and repealing directive 84/466/EURATOM (June).
-
Council Directive 97/43/EURATOM on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, and repealing directive 84/466/EURATOM (June 1997).
-
(1997)
-
-
-
6
-
-
10844220088
-
-
International Commission on Radiation Units and Measurements Report No. 67, (unpublished); (Nuclear Technology, Ashford, England, 2002).
-
International Commission on Radiation Units and Measurements Report No. 67, 2002 (unpublished); Absorbed-Dose Specification in Nuclear Medicine (Nuclear Technology, Ashford, England, 2002).
-
(2002)
Absorbed-Dose Specification in Nuclear Medicine
-
-
-
7
-
-
1542286684
-
Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism
-
0144-8420 10.1093/rpd/nch013.
-
H. Jönsson and S. Mattsson, " Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism.," Radiat. Prot. Dosim. 0144-8420 10.1093/rpd/nch013 108, 107-114 (2004).
-
(2004)
Radiat. Prot. Dosim.
, vol.108
, pp. 107-114
-
-
Jönsson, H.1
Mattsson, S.2
-
8
-
-
0000969129
-
-
edited by R. E. Hankin (Mosby, St. Louis), Vol.
-
M. G. Stabin, Internal Radiation Dosimetry in Nuclear Medicine, edited by, R. E. Hankin, (Mosby, St. Louis, 1996), Vol. I, pp. 316-333.
-
(1996)
Internal Radiation Dosimetry in Nuclear Medicine
, vol.1
, pp. 316-333
-
-
Stabin, M.G.1
-
9
-
-
0037035397
-
A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease
-
0031-9155 10.1088/0031-9155/47/9/305.
-
F. Di Martino, A. C. Traino, A. B. Brill, M. G. Stabin, and M. Lazzeri, " A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/47/9/305 47, 1493-1499 (2002).
-
(2002)
Phys. Med. Biol.
, vol.47
, pp. 1493-1499
-
-
Di Martino, F.1
Traino, A.C.2
Brill, A.B.3
Stabin, M.G.4
Lazzeri, M.5
-
10
-
-
3142695423
-
A dosimetric approach to patient specific radioiodine treatment of Graves' disease with incorporation of treatment induced changes in thyroid mass
-
0094-2405 10.1118/1.1763411.
-
A. C. Traino, F. Di Martino, and M. Lazzeri, " A dosimetric approach to patient specific radioiodine treatment of Graves' disease with incorporation of treatment induced changes in thyroid mass.," Med. Phys. 0094-2405 10.1118/1.1763411 31, 2121-2127 (2004).
-
(2004)
Med. Phys.
, vol.31
, pp. 2121-2127
-
-
Traino, A.C.1
Di Martino, F.2
Lazzeri, M.3
-
11
-
-
0026653895
-
New simple method for thyroid volume determination by ultrasonography
-
0091-2751 10.1002/jcu.1870200505.
-
A. Szebeni and E. Beleznay, " New simple method for thyroid volume determination by ultrasonography.," J. Clin. Ultrasound 0091-2751 10.1002/jcu.1870200505 20, 329-339 (1992).
-
(1992)
J. Clin. Ultrasound
, vol.20
, pp. 329-339
-
-
Szebeni, A.1
Beleznay, E.2
-
12
-
-
39449127301
-
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
-
C. Kobe, W. Eschner, F. Sudbrock, I. Weber, K. Marx, M. Dietlein, and H. Schicha, " Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?," Nuklearmedizin 47, 13-17 (2008).
-
(2008)
Nuklearmedizin
, vol.47
, pp. 13-17
-
-
Kobe, C.1
Eschner, W.2
Sudbrock, F.3
Weber, I.4
Marx, K.5
Dietlein, M.6
Schicha, H.7
|